REZLIDHIA

OLUTASIDENIB · Rigel Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REZLIDHIA, covering 2022-12-01 to 2022-12-01. Get the full timeline:

Most recent: FDA Approved: REZLIDHIA — Original Application (Rigel Pharmaceuticals, Inc.)